Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2020
A Performance Comparison of Commonly Used Assays to Detect RET FusionsSoo-Ryum Yang, Umut Aypar, Ezra Y Rosen, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 4, 2019
NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfallsJames P Solomon, Irina Linkov, Andrea Rosado, et al.Cancer Research|January 16, 2019
Colorectal Carcinomas Containing Hypermethylated MLH1 Promoter and Wild-Type BRAF/KRAS Are Enriched for Targetable Kinase FusionsEmiliano Cocco, Jamal Benhamida, Sumit Middha, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2019
High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation BurdenRyma Benayed, Michael Offin, Kerry Mullaney, et al.The Journal of Molecular Diagnostics : JMD|May 17, 2025
Leveraging RNA from DNA Extraction Lysate to Rescue "Insufficient" Samples for More Comprehensive Genomic Profiling in Patients with Scant Tumor SpecimensMark D Ewalt, Sara E DiNapoli, Kerry Mullaney, et al.The Journal of Molecular Diagnostics : JMD|December 7, 2020
A Pan-Cancer Study of Somatic TERT Promoter Mutations and Amplification in 30,773 Tumors Profiled by Clinical Genomic SequencingSounak Gupta, Chad M Vanderbilt, Yun-Te Lin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2024
Tumor-Agnostic Genomic and Clinical Analysis of BRAF Fusions Identifies Actionable TargetsMonica F Chen, Soo-Ryum Yang, Jessica J Tao, et al.The Journal of Clinical Investigation|June 20, 2018
Oncogenic TRK fusions are amenable to inhibition in hematologic malignanciesJustin Taylor, Dean Pavlick, Akihide Yoshimi, et al.Molecular Cancer Research : MCR|October 23, 2023
Impact of Rare and Multiple Concurrent Gene Fusions on Diagnostic DNA Methylation Classifier in Brain TumorsKristyn Galbraith, Jonathan Serrano, Guomiao Shen, et al.Pageof 2